246 related articles for article (PubMed ID: 28900170)
41. Polymorphic α-Synuclein Strains Modified by Dopamine and Docosahexaenoic Acid Interact Differentially with Tau Protein.
Sengupta U; Puangmalai N; Bhatt N; Garcia S; Zhao Y; Kayed R
Mol Neurobiol; 2020 Jun; 57(6):2741-2765. PubMed ID: 32350746
[TBL] [Abstract][Full Text] [Related]
42. Functional Interplay between Arginyl-tRNA Synthetases and Arginyltransferase.
Avcilar-Kucukgoze I; MacTaggart B; Kashina A
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077558
[TBL] [Abstract][Full Text] [Related]
43. Biasing the native α-synuclein conformational ensemble towards compact states abolishes aggregation and neurotoxicity.
Carija A; Pinheiro F; Pujols J; Brás IC; Lázaro DF; Santambrogio C; Grandori R; Outeiro TF; Navarro S; Ventura S
Redox Biol; 2019 Apr; 22():101135. PubMed ID: 30769283
[TBL] [Abstract][Full Text] [Related]
44. Reduced passive force in skeletal muscles lacking protein arginylation.
Leite FS; Minozzo FC; Kalganov A; Cornachione AS; Cheng YS; Leu NA; Han X; Saripalli C; Yates JR; Granzier H; Kashina AS; Rassier DE
Am J Physiol Cell Physiol; 2016 Jan; 310(2):C127-35. PubMed ID: 26511365
[TBL] [Abstract][Full Text] [Related]
45. Assaying ATE1 Activity In Vitro.
Wang J; Kashina AS
Methods Mol Biol; 2023; 2620():113-117. PubMed ID: 37010756
[TBL] [Abstract][Full Text] [Related]
46. N-Terminal Arginylation Pull-down Analysis Using the R-Catcher Tool.
Seo T; Han G; Cha-Molstad H
Methods Mol Biol; 2023; 2620():219-228. PubMed ID: 37010765
[TBL] [Abstract][Full Text] [Related]
47. Transglutaminase 2 exacerbates α-synuclein toxicity in mice and yeast.
Grosso H; Woo JM; Lee KW; Im JY; Masliah E; Junn E; Mouradian MM
FASEB J; 2014 Oct; 28(10):4280-91. PubMed ID: 24970392
[TBL] [Abstract][Full Text] [Related]
48. Arginylation-dependent regulation of a proteolytic product of talin is essential for cell-cell adhesion.
Zhang F; Saha S; Kashina A
J Cell Biol; 2012 Jun; 197(6):819-36. PubMed ID: 22665520
[TBL] [Abstract][Full Text] [Related]
49. Role of neurotoxicants and traumatic brain injury in α-synuclein protein misfolding and aggregation.
Rokad D; Ghaisas S; Harischandra DS; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
Brain Res Bull; 2017 Jul; 133():60-70. PubMed ID: 27993598
[TBL] [Abstract][Full Text] [Related]
50. Crystal structure of the Ate1 arginyl-tRNA-protein transferase and arginylation of N-degron substrates.
Kim BH; Kim MK; Oh SJ; Nguyen KT; Kim JH; Varshavsky A; Hwang CS; Song HK
Proc Natl Acad Sci U S A; 2022 Aug; 119(31):e2209597119. PubMed ID: 35878037
[TBL] [Abstract][Full Text] [Related]
51. Identification of mammalian arginyltransferases that modify a specific subset of protein substrates.
Rai R; Kashina A
Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10123-8. PubMed ID: 16002466
[TBL] [Abstract][Full Text] [Related]
52. In vitro models of synucleinopathies: informing on molecular mechanisms and protective strategies.
Marvian AT; Koss DJ; Aliakbari F; Morshedi D; Outeiro TF
J Neurochem; 2019 Sep; 150(5):535-565. PubMed ID: 31004503
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA-7 facilitates the degradation of alpha-synuclein and its aggregates by promoting autophagy.
Choi DC; Yoo M; Kabaria S; Junn E
Neurosci Lett; 2018 Jun; 678():118-123. PubMed ID: 29738845
[TBL] [Abstract][Full Text] [Related]
54. Arginyltransferase ATE1 is targeted to the neuronal growth cones and regulates neurite outgrowth during brain development.
Wang J; Pavlyk I; Vedula P; Sterling S; Leu NA; Dong DW; Kashina A
Dev Biol; 2017 Oct; 430(1):41-51. PubMed ID: 28844905
[TBL] [Abstract][Full Text] [Related]
55. The preparation of recombinant arginyltransferase 1 (ATE1) for biophysical characterization.
Cartwright M; Van V; Smith AT
Methods Enzymol; 2023; 679():235-254. PubMed ID: 36682863
[TBL] [Abstract][Full Text] [Related]
56. Self-Assembled Cyclic d,l-α-Peptides as Generic Conformational Inhibitors of the α-Synuclein Aggregation and Toxicity: In Vitro and Mechanistic Studies.
Chemerovski-Glikman M; Rozentur-Shkop E; Richman M; Grupi A; Getler A; Cohen HY; Shaked H; Wallin C; Wärmländer SK; Haas E; Gräslund A; Chill JH; Rahimipour S
Chemistry; 2016 Sep; 22(40):14236-46. PubMed ID: 27539220
[TBL] [Abstract][Full Text] [Related]
57. Loss of ATE1-mediated arginylation leads to impaired platelet myosin phosphorylation, clot retraction, and in vivo thrombosis formation.
Lian L; Suzuki A; Hayes V; Saha S; Han X; Xu T; Yates JR; Poncz M; Kashina A; Abrams CS
Haematologica; 2014 Mar; 99(3):554-60. PubMed ID: 24293517
[TBL] [Abstract][Full Text] [Related]
58. C-terminal truncation exacerbates the aggregation and cytotoxicity of α-Synuclein: A vicious cycle in Parkinson's disease.
Ma L; Yang C; Zhang X; Li Y; Wang S; Zheng L; Huang K
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3714-3725. PubMed ID: 30290273
[TBL] [Abstract][Full Text] [Related]
59. Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies.
Peng C; Gathagan RJ; Lee VM
Neurobiol Dis; 2018 Jan; 109(Pt B):209-218. PubMed ID: 28751258
[TBL] [Abstract][Full Text] [Related]
60. α-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic Neurodegeneration.
Abdelmotilib H; Maltbie T; Delic V; Liu Z; Hu X; Fraser KB; Moehle MS; Stoyka L; Anabtawi N; Krendelchtchikova V; Volpicelli-Daley LA; West A
Neurobiol Dis; 2017 Sep; 105():84-98. PubMed ID: 28576704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
